Aquipta Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Atogepant

Indications/Uses

Prophylaxis of migraine in adults who have at least 4 migraine days per mth.

Click to view Aquipta detailed prescribing information

Dosage/Direction for Use

60 mg once daily. Patient w/ severe renal impairment (CrCl 15-29 mL/min) & ESRD (CrCl <15 mL/min) 10 mg once daily. Should be taken after dialysis by patients w/ ESRD undergoing intermittent dialysis.

Click to view Aquipta detailed prescribing information

Overdosage

View Aquipta overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Swallow whole. Do not split/crush/chew.

Contraindications

Hypersensitivity.

Click to view Aquipta detailed prescribing information

Special Precautions

May cause somnolence. Exercise caution before driving or using machinery. 60-mg tab contains 31.5 mg Na per tab. Not recommended in patients w/ severe hepatic impairment, during pregnancy, & in women of childbearing potential not using contraception. Decide whether to discontinue breast-feeding or discontinue/abstain from therapy taking into account the benefit of breast-feeding for the child & the benefit of therapy for the woman. Safety & efficacy in childn <18 yr have not yet been established.

Click to view Aquipta detailed prescribing information

Use In Pregnancy & Lactation

Click to view Aquipta detailed prescribing information

Adverse Reactions

Decreased appetite; nausea, constipation; fatigue/somnolence; decreased wt.

Click to view Aquipta detailed prescribing information

Drug Interactions

Increased systemic exposure w/ strong CYP3A4 inhibitors (eg, ketoconazole, itraconazole, clarithromycin, ritonavir) &/or OATP inhibitors (eg, rifampicin, ciclosporin, ritonavir).

Click to view Aquipta detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Aquipta detailed prescribing information

Storage

View Aquipta storage conditions for details to ensure optimal shelf-life.

Description

View Aquipta description for details of the chemical structure and excipients (inactive components).

Action

View Aquipta mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antimigraine Preparations

ATC Classification

N02CD07 - atogepant ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.

Regulatory Classification

P₁S₁S₃

Presentation/Packing

Form

Aquipta tab 10 mg

Packing/Price

28's

Form

Aquipta tab 60 mg

Packing/Price

28's

Aquipta

Manufacturer:

Forest Laboratories Ireland

Distributor:

DKSH

Marketer:

AbbVie